Hikma Pharmaceuticals PLC carries a market capitalization of 4.49B, placing it among publicly traded companies globally.
| Market Cap | 4.49B |
| Enterprise Value | N/A |
Hikma Pharmaceuticals PLC's stock has declined approximately -12.95547% over the past 52 weeks. The 50-day moving average sits at 43.33, while the 200-day moving average is 40.29.
| Beta (5Y) | N/A |
| 52-Week Price Change | -12.95547% |
| 50-Day Moving Average | 43.33 |
| 200-Day Moving Average | 40.29 |
| Average Volume (20 Days) | N/A |